Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew D. Sklawer currently holds 39,269 shares of Fresh Tracks Therapeutics, Inc. (FRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew D. Sklawer has been a net buyer of FRTX stock. They have purchased $12.3K and sold $0 worth of shares.
Andrew D. Sklawer's most recent insider trade was on Oct 2, 2023, when they sold 20,833 shares at $0.98 per share.
Andrew D. Sklawer serves as Executive at Fresh Tracks Therapeutics, Inc. (FRTX). They have executed 6 insider transactions totaling $12.3K over their tenure at the company.
Andrew D. Sklawer holds the position of Executive at Fresh Tracks Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew D. Sklawer has shown a buying trading pattern, with $12.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew D. Sklawer was on Oct 2, 2023, when they sold $20.4K worth of FRTX shares. This transaction involved 20,833 shares at $0.98 per share.
Andrew D. Sklawer currently owns 39,269 shares of Fresh Tracks Therapeutics, Inc. (FRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew D. Sklawer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew D. Sklawer has 6 Form 4 filings on record as an insider at Fresh Tracks Therapeutics, Inc..
Set alerts for Andrew D. Sklawer and 40,000+ other insiders.